Quantbot Technologies LP Increases Stock Position in Envista Holdings Co. (NYSE:NVST)

Quantbot Technologies LP boosted its position in Envista Holdings Co. (NYSE:NVSTFree Report) by 67.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 326,653 shares of the company’s stock after acquiring an additional 131,680 shares during the quarter. Quantbot Technologies LP’s holdings in Envista were worth $5,432,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Envista by 5.8% during the 4th quarter. Vanguard Group Inc. now owns 17,167,767 shares of the company’s stock worth $413,056,000 after purchasing an additional 944,596 shares during the period. Ariel Investments LLC boosted its stake in shares of Envista by 25.3% in the first quarter. Ariel Investments LLC now owns 8,892,200 shares of the company’s stock valued at $190,115,000 after purchasing an additional 1,795,258 shares during the period. Nuance Investments LLC grew its holdings in Envista by 47.2% during the 2nd quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock valued at $117,048,000 after purchasing an additional 2,256,993 shares in the last quarter. American Century Companies Inc. increased its stake in Envista by 15.4% during the 2nd quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock worth $111,864,000 after buying an additional 897,141 shares during the period. Finally, Franklin Resources Inc. lifted its holdings in Envista by 65.3% in the 4th quarter. Franklin Resources Inc. now owns 5,262,092 shares of the company’s stock worth $126,606,000 after buying an additional 2,077,786 shares in the last quarter.

Envista Price Performance

Shares of NVST opened at $19.41 on Monday. Envista Holdings Co. has a 12 month low of $15.15 and a 12 month high of $29.80. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.22 and a quick ratio of 1.90. The stock has a fifty day moving average price of $17.13 and a 200 day moving average price of $18.53. The company has a market cap of $3.34 billion, a P/E ratio of -26.96 and a beta of 1.31.

Envista (NYSE:NVSTGet Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.27 by ($0.16). The firm had revenue of $633.10 million for the quarter, compared to the consensus estimate of $646.88 million. Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The firm’s revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.43 EPS. On average, research analysts forecast that Envista Holdings Co. will post 0.69 earnings per share for the current year.

Insider Transactions at Envista

In other Envista news, CFO Eric D. Hammes purchased 24,532 shares of Envista stock in a transaction on Monday, August 12th. The stock was bought at an average price of $16.33 per share, for a total transaction of $400,607.56. Following the transaction, the chief financial officer now owns 24,532 shares of the company’s stock, valued at approximately $400,607.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on NVST. JPMorgan Chase & Co. downgraded Envista from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $23.00 to $16.00 in a research note on Thursday, August 8th. Evercore ISI lowered their price objective on Envista from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Stifel Nicolaus cut their target price on Envista from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, July 30th. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Thursday, August 8th. Finally, Bank of America dropped their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.14.

Get Our Latest Stock Report on Envista

Envista Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

See Also

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.